Risk assessment report of potential impurities in cetirizine dihydrochloride.

Recently, the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) had reported on "unexpected" impurities in a couple of sartans, ranitidine, and metformin.